Regina is an Advisor at Collateral Good. With over 18 years of expertise in the biotech and pharmaceutical industries, Regina has worked across prominent corporate institutions and research facilities throughout Europe. Her professional journey includes roles such as Global Business Development Manager at Hoffmann-La Roche and Portfolio Manager at Evolva Group, where she drove strategic growth and innovation. She also held leadership positions as Partner at Blue Horizon Ventures, and currently General Manager at CureOmics, contributing to transformative advancements in the sector.

Her academic background is equally impressive, with a PhD in Molecular & Cell Biology from the University of Zurich, a Master in Biotechnology Management from IE Business School in Madrid, and a Master of Engineering in Biotechnology. She is also certified in Plant-Based Nutrition from the T. Colin Campbell Center for Nutrition Studies. Earlier in her career, she conducted research at the Max Planck Institute in Germany and worked at Bank Vontobel and the University Children’s Hospital Zurich, combining her scientific expertise with business acumen to excel in highly impactful roles.